Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or Contaminated Cases
Flex HD
1 other identifier
interventional
35
1 country
1
Brief Summary
This study examines the feasibility of using Flex HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrixin the repair of hernias.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 9, 2012
CompletedFirst Posted
Study publicly available on registry
May 11, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedResults Posted
Study results publicly available
March 16, 2017
CompletedMarch 16, 2017
October 1, 2016
4.2 years
May 9, 2012
June 24, 2016
January 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Hernia Recurrence
Recurrence of hernia based on physical exam and /or CT scan.
12 months
Wound Occurrence
superficial or deep wound infection, abscess, seroma, cellulitis, necrosis, hematoma or wound dehiscence.
12 months
Wound Occurrence: Deep Wound Infection
12 Months
Wound Occurrence: Wound Abscess
12 Months
Wound Occurrence: Wound Seroma
12 Months
Wound Occurrence: Wound Cellulitis
12 Months
Wound Occurrence: Wound Dehiscence
12 Months
Wound Occurrence: Superficial Wound Infection
Superficial wound infection
12 months
Change in SF12 Physical Component Score Between Pre-operation and 12 Months Post-operation
Change in SF12 Physical Component Score from pre-operation to 12 months post-operation: Scores were normalized with 50 equal to the national norm and 40 equal to one standard deviation below the norm, so a 12 month difference of 10 would equal a 1 standard deviation change; An increase is better.
12 months
Change in SF12 Mental Component Score Between Pre-operation and 12 Months Post-operation
Change in SF12 Mental Component Score from pre-operation to 12 months post-operation: Scores were normalized with 50 equal to the national norm and 40 equal to one standard deviation below the norm; An increase is better.
12 months
Study Arms (2)
Flex HD
ACTIVE COMPARATORMesh Type
Strattice
ACTIVE COMPARATORUse of a second mesh type
Interventions
Eligibility Criteria
You may qualify if:
- Be 18-85 years of age (inclusive)
- Patient has a ventral or incisional hernia with at least one of the following characteristics
- Hernia is at least 6cm in transverse dimension
- History of 2 or more prior ventral or incisional hernia repairs
- Active or prior infection of the abdominal wall
- Enterocutaneous fistula to the anterior abdominal wall
- Mesh requiring mesh removal which would result in a hernia at least 6cm in transverse dimension
- Patients is scheduled to undergo component separation hernia repair
- Have an ASA Score of 3 or less
- Have a BMI between 20 and 55
- Be a candidate for primary approximation of skin and wound following hernia repair
- Have a life expectancy of at least 2 years
You may not qualify if:
- Have loss of abdominal domain such that the operation would be impractical or would adversely effect respiratory or cardiovascular function to an unacceptable degree
- Be a candidate for emergency surgery that would make giving valid Informed Consent impractical
- Be currently taking part in another clinical study that conflicts with the current study
- Have active generalized peritonitis or intraperitoneal sepsis
- Have active necrotizing fasciitis
- Have active abdominal compartment syndrome
- Have active untreated metabolic or systemic illness
- Have known active malignancy present
- Be unable to give valid informed consent or comply with required follow-up schedule
- Suffer from mental capacity sufficiently severe to make informed consent unobtainable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- John Rothlead
Study Sites (1)
University of Kentucky Medical Center
Lexington, Kentucky, 40536, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This is a Prospective Quasi-experimental study. Patients were randomized in the traditional sense.
Results Point of Contact
- Title
- J. Scott Roth, M.D.
- Organization
- University of Kentucky Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
John S Roth, M.D.
University of Kentucky
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
May 9, 2012
First Posted
May 11, 2012
Study Start
March 1, 2011
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
March 16, 2017
Results First Posted
March 16, 2017
Record last verified: 2016-10